Drug Information

Drug General Information
Drug ID
D0G2MW
Former ID
DAP000969
Drug Name
Icosapent
Synonyms
Icosapento; Icosapentum; Eicosapentaenoic acid; Icosapentaenoic acid; Timnodonic acid; E0441; BML3-B01; Icosapento [INN-Spanish]; Icosapentum [INN-Latin]; EICOSAPENTAENOIC ACID (20:5 n-3); All cis-5,8,11,14,17-Eicosapentaenoic Acid; All cis-5,8,11,14,17-Icosapentaenoic Acid; Cis-5,8,11,14,17-EPA; Cis-5,8,11,14,17-Eicosapentaenoic acid; Cis-Delta(5,8,11,14,17)-eicosapentaenoic acid; All-cis-icosa-5,8,11,14,17-pentaenoic acid; Cis, cis, cis, cis, cis-eicosa-5,8,11,14,17-pentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate; (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid; (Z,Z,Z,Z,Z)-5,8,11,14,17-eicosapentaenoic acid; (all-Z)-5,8,11,14,17-Eicosapentaenoic acid; (all-Z)-delta5,8,11,14,17-Eicosapentaenoic acid; (all-cis)-5,8,11,14,17-Eicosapentaenoic acid; 5,8,11,14,17-EICOSAPENTAENOIC ACID; 5,8,11,14,17-Eicosapentaenoic acid (6CI); 5,8,11,14,17-Eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-(9CI); 5,8,11,14,17-Eicosapentaenoic acid, (all-Z)-(8CI); 5,8,11,14,17-Icosapentaenoic acid; 5Z,8Z,11Z,14Z,17Z-Eicosapentaenoic acid; 7F8BF016-B146-4F72-A52E-B9298BA3A9AB
Drug Type
Small molecular drug
Indication Hyperglyceridemic [ICD9: 790.29; ICD10:R73.9] Approved [542465], [550112]
Therapeutic Class
Dietary supplement
Structure
Download
2D MOL

3D MOL
Formula
C22H34O2
InChI
InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-
InChIKey
SSQPWTVBQMWLSZ-AAQCHOMXSA-N
CAS Number
CAS 10417-94-4
PubChem Compound ID
9831415
PubChem Substance ID
7848954, 14851023, 24132245, 44929533, 47205492, 49964825, 57373458, 71821310, 77834595, 87569697, 92308211, 99006112, 104179160, 117663994, 125307497, 125309298, 126666714, 135029488, 135114359, 135727811, 143077352, 144076075, 160686878, 162064799, 162262088, 175266496, 175268968, 175427134, 175611317, 178104013, 179117039, 223445352, 223680105, 224382965, 226494419, 242084018, 250134289, 252466658, 252816326
ChEBI ID
ChEBI:28364
Target and Pathway
Target(s) Cyclooxygenase Target Info Binder [535691]
References
Ref 542465(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7441).
Ref 550112Drug information of Icosapent, Health Canada, 2007.
Ref 535691Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res. 2003 Mar;44(3):479-86. Epub 2002 Dec 1.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.